Form 4: Oruka Therapeutics COO Sells Shares
Insider Transaction (Form 4)
Laura Lee Sandler, Chief Operating Officer of Oruka Therapeutics, Inc., sold 906 shares of common stock on September 15, 2026 for $95.71 per share.
Summary
- Open-market sale: disposed of 906 Common Stock at $95.71 ($86,713) on September 15, 2026; holds 235,478 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $86,713 of stock on the open market.
Insider Transactions
Laura Lee Sandler — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market sale | Common Stock | 906 | $96 | $86.7K | 235,478 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market sale (906 shares) |
Keywords
insider transaction, Form 4, ORKA, Oruka Therapeutics, Inc., bearish, Laura Lee Sandler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.